Date: October 7 - 9, 2026
Location: Pacifico Yokohama

Japan set the pace for iPSC-derived cell therapy, from the foundational reprogramming science to this year's conditional regulatory approvals for iPSC-derived treatments. Cellistic will join that momentum at BioJapan 2026, October 7–9, at PACIFICO Yokohama, held alongside Regenerative Medicine JAPAN and healthTECH JAPAN.

Cellistic will be part of the Belgian Pavilion, organized by AWEX (Wallonia Export & Investment Agency), with Fionn Huang, Senior Director Business Development, APAC, on site for the full event. We would welcome the opportunity to meet with organizations advancing cell and gene therapy programs in Japan and across the region.

Cellistic has spent more than 15 years turning iPSC science into GMP manufacturing capacity, with an EMA-inspected facility in Belgium, Europe. At BioJapan, we look forward to discussing where your program's manufacturing path stands today, and how that track record can support it going forward.

We look forward to meeting you at the Belgian Pavilion. If you would like to schedule time with Fionn Huang, please reach out in advance.

Schedule a meeting with Fionn